4//SEC Filing
Fitzpatrick Mark J. 4
Accession 0001209191-18-013680
CIK 0001339469other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 9:06 PM ET
Size
8.1 KB
Accession
0001209191-18-013680
Insider Transaction Report
Form 4
CHIASMA, INCCHMA
Fitzpatrick Mark J.
CFO, Treasurer
Transactions
- Award
Stock Option (Right to Buy)
2018-02-23+67,967→ 67,967 totalExercise: $1.52Exp: 2028-02-23→ Common Stock (67,967 underlying) - Award
Stock Option (Right to Buy)
2018-02-23+194,183→ 194,183 totalExercise: $1.52Exp: 2028-02-23→ Common Stock (194,183 underlying)
Footnotes (2)
- [F1]The shares of Common Stock underlying the option will vest in quarterly installments over 4 years from the date of grant.
- [F2]The shares of Common Stock underlying the option will vest as follows: 40% of such award will be earned upon FDA acceptance of a new drug application (NDA) for Mycapssa, of which amount 50% will be immediately vested and 50% will vest upon the one year anniversary of such acceptance; 60% of such award will be earned upon FDA approval of such NDA, of which amount 50% will be immediately vested and 50% will vest upon the one year anniversary of such approval.
Documents
Issuer
CHIASMA, INC
CIK 0001339469
Entity typeother
Related Parties
1- filerCIK 0001520265
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 9:06 PM ET
- Size
- 8.1 KB